Science
Bias in the WHO's report on the Social Determinants of Health
IPN Opinion article
IPN argues in the Lancet that the WHO is guilty of failing to look at all the evidence in its report of the relationship between economic development and health.
Innovation and Access?
Delegates at the World Health Assembly are currently discussing a draft plan of action on public health, innovation and intellectual property, the outcome of which could have wide-ranging implications for innovation and access to medicines. Featuring Franklin Cudjoe (Imani) and Barun Mitra (Liberty Institute)
Australian launch of Fighting the Diseases of Poverty
Featuring: Tim Wilson, Institute of Public Affairs, and Philip Stevens, International Policy Network and Editor of Fighting the Diseases of Poverty
Medicines for the poor: not the Oxfam way
IPN Opinion article
The registration of new medicines fell sharply in the last year in the USA, while Oxfam calls for a compulsory pricing structure and backs the compulsory licenses sought by Thailand and threatened by Brazil and Indonesia. There are indeed other problems facing pharmaceutical companies but the campaign against patents is a major one: when Big Pharma gives up investing in innovation, where will new medicines come from? The price of punishing Big Pharma is to punish the poor harder.
Intellectual Property, Innovation and Healthcare in Less-Developed Countries
A lunchtime conference on intellectual property rights, innovation and the provision of healthcare in poor countries. The event coincides with the first day of the Pan-American Health Organisation General Meeting.
IP fixation is bad for health
IPN Opinion article
International NGO campaigns in India have given the misleading impression that patents are the single most important barrier to good health in less-developed countries. This fallacy is drawing attention away from the real causes of disease.
